Medicine Recommendations

LSCMMG

Amber 0

BwD

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Roflumilast

Date Posted: 01 - Sep - 2017

BNF chapter: Respiratory system

Expand/Collapse

Treating chronic obstructive pulmonary disease (NICE TA461)

NICE TA461 - Roflumilast for treating chronic obstructive pulmonary disease

Red

Red

Red

Red

Red

Red

Red

Red

Red

Romiplostim

Date Posted: 01 - Nov - 2018

BNF chapter: Blood and Nutrition

Expand/Collapse

Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura (NICE TA221)

NICE TA221 - Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura

Red

Red

Red

Red

Red

Red

Red

Red

Red

Romosozumab

Date Posted: 15 - Jul - 2022

BNF chapter: Endocrine system

Expand/Collapse

Severe osteoporosis (NICE TA791)

NICE TA791 - Romosozumab for treating severe osteoporosis

Green

Green

Green

Green

Green

Green

Green

Green

Green

Ropinirole

Date Posted: 01 - Dec - 2015

BNF chapter: Central nervous system

Expand/Collapse

Restless Legs Syndrome (as per LSCMMG Guidelines)

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Ropinirole

Date Posted: 01 - May - 2013

BNF chapter: Central nervous system

Expand/Collapse

Parkinsons disease

LSCMMG

Green (R)(Restricted)

BwD

Pending

BP

Green

CSR

Green (R)(Restricted)

EL

Pending

FW

Green (R)(Restricted)

GP

Green (R)(Restricted)

MB

Green (R)(Restricted)

WL

Green (R)(Restricted)

Rotigotine

Date Posted: 01 - Dec - 2015

BNF chapter: Central nervous system

Expand/Collapse

Restless Legs Syndrome (as per LSCMMG Guidelines)

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Rotigotine

Date Posted: 01 - Dec - 2015

BNF chapter: Central nervous system

Expand/Collapse

Parkinsons Disease

Red

Red

Red

Red

Red

Red

Red

Red

Red

Roxadustat

Date Posted: 14 - Sep - 2022

BNF chapter: Endocrine system

Expand/Collapse

Treating symptomatic anaemia in chronic kidney disease - NICE TA807

NICE TA807 - Roxadustat for treating symptomatic anaemia in chronic kidney disease

Black

Black

Black

Black

Black

Black

Black

Black

Black

Rubefacients (excluding topical non-steroidal anti-inflammatory drugs)

Date Posted: 01 - Dec - 2017

BNF chapter: Musculoskeletal system

Expand/Collapse

This colour classification is in agreement with the recommendations contained within the NHS England and NHS Clinical Commissioners guidance document ‘Items which should not routinely be prescribed in primary care: Guidance for CCGs‘ published in November 2017

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Pending

Rufinamide

Date Posted: 01 - Oct - 2014

BNF chapter: Central nervous system

Expand/Collapse

Adjunct treatment of seizures in Lennox-Gastaut syndrome

MHRA Drug Safety Update - Antiepileptic drugs: updated advice on switching between different manufacturers’ products

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Sacubitril valsartan

Date Posted: 01 - May - 2016

BNF chapter: Cardiovascular system

Expand/Collapse

Treating symptomatic chronic heart failure with reduced ejection fraction (NICE TA388)

NICE TA388 - Sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fraction

Black

Black

Black

Black

Black

Black

Black

Black

Black

Safinamide

Date Posted: 01 - Dec - 2016

BNF chapter: Central nervous system

Expand/Collapse

Treatment of adult patients with idiopathic Parkinson’s disease (PD) as add-on therapy to a stable dose of levodopa (L-dopa) alone or in combination with other PD medicinal products in mid to late stage fluctuating patients

Palliative Use Only

LSCMMG

Green (R)(Restricted)

BwD

Green (R)(Restricted)

BP

Green (R)(Restricted)

CSR

Green (R)(Restricted)

EL

Green (R)(Restricted)

FW

Green (R)(Restricted)

GP

Green (R)(Restricted)

MB

Green (R)(Restricted)

WL

Green (R)(Restricted)

Salbutamol 2.5mg nebules

Date Posted: 24 - Mar - 2022

BNF chapter: Respiratory system

Breathlessness

Red

Red

Red

Red

Red

Red

Red

Red

Red

Sarilumab

Date Posted: 01 - Dec - 2017

BNF chapter: Musculoskeletal system

Expand/Collapse

Rheumatoid arthritis (LSCMMG pathway)

Black

Black

Black

Black

Black

Black

Black

Black

Pending

Secobarbital

Date Posted: 18 - Oct - 2019

BNF chapter: Central nervous system

Expand/Collapse

Severe intractable insomnia only in patients already taking barbiturates

The colour classification was determined as part of the collaborative work between LCFT and medicines Management leads. Local pathways and patient safety were taken into consideration.

Red

Red

Red

Red

Red

Red

Red

Red

Red

Secukinumab

Date Posted: 10 - Sep - 2021

BNF chapter: Musculoskeletal system

Expand/Collapse

For treating non-radiographic axial spondyloarthritis.

NICE TA719 - Secukinumab for treating non-radiographic axial spondyloarthritis

Red

Red

Red

Red

Red

Red

Red

Red

Red

Secukinumab

Date Posted: 01 - Oct - 2017

BNF chapter: Skin

Expand/Collapse

Palmoplantar psoriasis

Red

Red

Red

Red

Red

Red

Red

Red

Red

Secukinumab

Date Posted: 01 - Sep - 2015

BNF chapter: Skin

Expand/Collapse

Moderate to Severe Plaque Psoriasis (NICE TA350)

NICE TA 350 - Secukinumab for treating moderate to severe plaque psoriasis

Red

Red

Red

Red

Red

Red

Red

Red

Red

Secukinumab

Date Posted: 01 - Oct - 2016

BNF chapter: Musculoskeletal system

Expand/Collapse

Active ankylosing spondylitis after treatment with non-steroidal anti-inflammatory drugs or TNF-alpha inhibitors (NICE TA407)

NICE TA407 - Secukinumab for active ankylosing spondylitis after treatment with non-steroidal anti-inflammatory drugs or TNF-alpha inhibitors

Red

Red

Red

Red

Red

Red

Red

Red

Red

Secukinumab

Date Posted: 01 - Jun - 2017

BNF chapter: Musculoskeletal system

Expand/Collapse

Breadcrumb

Medicine Recommendations

Treating chronic obstructive pulmonary disease (NICE TA461)

Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura (NICE TA221)

Restless Legs Syndrome (as per LSCMMG Guidelines)

Parkinsons disease

Restless Legs Syndrome (as per LSCMMG Guidelines)

Parkinsons Disease

This colour classification is in agreement with the recommendations contained within the NHS England and NHS Clinical Commissioners guidance document ‘Items which should not routinely be prescribed in primary care: Guidance for CCGs‘ published in November 2017

Adjunct treatment of seizures in Lennox-Gastaut syndrome

Treating symptomatic chronic heart failure with reduced ejection fraction (NICE TA388)

Treatment of adult patients with idiopathic Parkinson’s disease (PD) as add-on therapy to a stable dose of levodopa (L-dopa) alone or in combination with other PD medicinal products in mid to late stage fluctuating patients

Severe intractable insomnia only in patients already taking barbiturates

The colour classification was determined as part of the collaborative work between LCFT and medicines Management leads. Local pathways and patient safety were taken into consideration.

Palmoplantar psoriasis

Moderate to Severe Plaque Psoriasis (NICE TA350)

Active ankylosing spondylitis after treatment with non-steroidal anti-inflammatory drugs or TNF-alpha inhibitors (NICE TA407)

Secukinumab for treating active psoriatic arthritis after inadequate response to DMARDs (NICE TA445)